EVX V1
Alternative Names: Cytomegalovirus vaccine - Evaxion Biotech; EVX-V1Latest Information Update: 14 Dec 2022
At a glance
- Originator Evaxion Biotech
- Developer Evaxion Biotech; ExpreS2ion Biotechnologies
- Class Cytomegalovirus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cytomegalovirus infections